Based in Waltham, Massachusetts, Alkermes, Inc. is a well-established biopharmaceutical company with a strong focus on creating innovative treatments for central nervous system disorders like schizophrenia, depression, addiction, and multiple sclerosis. Founded to tackle some of the toughest challenges in medicine, the company has been led by CEO Richard Pops since 1991, transforming it from a small startup into an influential global entity that employs over 2,000 people.
Guided by leaders with deep expertise across various fields-James Robinson as President and COO brings extensive experience in sales, marketing, regulatory affairs, and HR; Kathy Biberstein manages legal and operational functions; while Iain Brown handles financial operations with more than two decades of industry know-how-the company continues to grow its comprehensive product offerings. Alkermes excels by maintaining a strong research presence dedicated to CNS diseases and by consistently focusing on innovation through an active clinical pipeline.
With robust commercial operations intertwined with strategic developments in research, Alkermes ensures financial stability and growth, making significant strides in patient care improvement and scientific progress. To discover more about their efforts and initiatives, you can visit Alkermes' official website at alkermes.com.
KEY FACTS ABOUT ALKERMES, INC.
-
US Businesses
-
Companies in Florida
-
Broward County Companies
- Company name
- ALKERMES, INC.
- Status
- Active
- Filed Number
- F05000003995
- FEI Number
- 23-2472830
- Date of Incorporation
-
July 12, 2005
Age - 22 years
- Home State
- PA
- Company Type
- Foreign for Profit
CONTACTS
- Website
- https://alkermes.com
- Phones
-
(781) 609-6000
(937) 382-5642
ALKERMES, INC. NEAR ME
- Principal Address
- 900 Winter Street,
Waltham,
MA,
02451,
US
See Also
Source:
ALKERMES, INC. on Florida Department of State, Division of Corporations